补肾活血颗粒治疗早发性卵巢功能不全的有效性与安全性:随机双盲安慰剂对照多中心临床试验方案
本研究为随机、双盲、安慰剂对照、多中心临床试验方案,计划在中国4家医院招募150例早发性卵巢功能不全(POI)女性,按1:1随机接受口服补肾活血(BSHX)颗粒或安慰剂,治疗3个月并随访3个月。主要结局为中文版绝经期生活质量量表(CMS)症状总分变化,次要结局包括血清性激素、抗苗勒管激素、卵巢收缩期峰值流速及窦卵泡计数。
要点
- 计划招募150例POI女性,1:1随机接受BSHX颗粒或安慰剂,治疗3个月、随访3个月。
- 主要结局为随机化前、3个月和6个月时CMS量表症状总分变化。
- 次要结局包括血清E2、LH、FSH、AMH、卵巢PSV(cm/s)及AFC,于干预前和随机化后3个月测量。
核心结论
- 该试验方案旨在评估BSHX颗粒治疗POI女性的有效性与安全性,目前尚未报告研究结果。
研究设计与样本
- 随机、双盲、安慰剂对照、多中心临床试验方案,计划在中国4家参与医院招募150例POI女性。
- 参与者按1:1随机接受口服BSHX颗粒或BSHX安慰剂,治疗3个月,随后随访3个月。
关键数值与推荐
- 主要结局为基于症状总分变化的中文版绝经期生活质量量表(CMS)问卷评分,于干预前、随机化后3个月和6个月测量。
- 其他测量包括血清性激素水平(E2、LH、FSH)、抗苗勒管激素(AMH)水平、卵巢收缩期峰值流速(PSV;cm/s)及窦卵泡计数(AFC),于干预前和随机化后3个月测量。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Premature ovarian insufficiency (POI) seriously affects the quality of life, endocrine function, and fertility of women of childbearing age. Currently, hormone replacement therapy for POI has some limitations, either with low efficacies or high side effects. Bushen Huoxue (BSHX) plays an important role in alleviating clinical symptoms and improving health status of POI patients. This placebo-controlled, randomized, double-blind, and multicenter clinical trial protocol aims to evaluate the effectiveness and safety of BSHX in women with POI. METHODS AND DESIGN: We plan to recruit 150 women with POI from four participating hospitals in China. Participants will be randomized in a 1:1 to receive oral BSHX or BSHX placebo. All participants will be treated for 3 months and will be followed up for another 3 month. The primary outcome is questionnaire scores based on the changes in the total symptoms, which is the Chinese version of the Menopause-Specific Quality of Life (CMS) (Nie G, Yang H, Liu J, Zhao C, Wang X, Menopause 24(5):546-554, 2017). CMS will be measured before the intervention, at 3 months and 6 months after randomization for all participants. The other measurements include serum sex hormone levels, anti-Müllerian hormone (AMH) levels, ovarian peak systolic velocity (PSV; cm/s), and antral follicle count (AFC). In this study, the regulatory effects of traditional Chinese medicine on hormones were evaluated by the changes of serum sex hormone levels, which include serum estradiol (E2), luteinizing hormone (LH), and follicle-stimulating hormone (FSH). These indicators will be measured before intervention and at 3 months after randomization. ETHICS AND DISSEMINATION: This study was approved by the Research Ethics Committee of Jiangsu Province Hospital on Integration of Chinese and Western Medicine (2019LWKY014). All participants will provide written informed consent prior to randomization. The results of this research will be presented to academic conferences and peer-reviewed journals. TRIAL REGISTRATION: ChiCTR1900028451. Registered on 22 December 2019, https://www.chictr.org.cn/index.aspx .
引用
- Cao Y, Peijuan-Wang, Lu Y, et al. Effectiveness and safety of Bushen Huoxue granules in treatment of premature ovarian insufficiency: study protocol for a randomized, double-blinded, placebo-controlled, and multicenter clinical trial. Trials. 2021. PMID: 34863269. doi:10.1186/s13063-021-05838-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。